ATE69956T1 - Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren. - Google Patents

Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren.

Info

Publication number
ATE69956T1
ATE69956T1 AT86904864T AT86904864T ATE69956T1 AT E69956 T1 ATE69956 T1 AT E69956T1 AT 86904864 T AT86904864 T AT 86904864T AT 86904864 T AT86904864 T AT 86904864T AT E69956 T1 ATE69956 T1 AT E69956T1
Authority
AT
Austria
Prior art keywords
pct
localization
diagnosis
tumors
image
Prior art date
Application number
AT86904864T
Other languages
English (en)
Inventor
Ward Page Faulk
Original Assignee
Ward Page Faulk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ward Page Faulk filed Critical Ward Page Faulk
Application granted granted Critical
Publication of ATE69956T1 publication Critical patent/ATE69956T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86904864T 1985-08-02 1986-08-01 Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren. ATE69956T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858519457A GB8519457D0 (en) 1985-08-02 1985-08-02 Tumour imaging agents
PCT/GB1986/000464 WO1987000756A1 (en) 1985-08-02 1986-08-01 Agents for use in tumour diagnosis, imaging, localization or treatment
EP86904864A EP0272257B1 (de) 1985-08-02 1986-08-01 Mittel für die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren

Publications (1)

Publication Number Publication Date
ATE69956T1 true ATE69956T1 (de) 1991-12-15

Family

ID=10583220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86904864T ATE69956T1 (de) 1985-08-02 1986-08-01 Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren.

Country Status (8)

Country Link
US (2) US4895714A (de)
EP (1) EP0272257B1 (de)
JP (1) JPS63502747A (de)
AT (1) ATE69956T1 (de)
AU (1) AU6198086A (de)
DE (1) DE3682780D1 (de)
GB (1) GB8519457D0 (de)
WO (1) WO1987000756A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206346A (en) * 1990-12-05 1993-04-27 E. I. Du Pont De Nemours And Company Method for iodination/purification
AU3783893A (en) * 1992-02-28 1993-09-13 Stanley E. Order Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
ATE452989T1 (de) 2000-03-27 2010-01-15 Univ Jefferson Zusammensetzungen und methoden zur identifizierung von krebszellen
WO2002000170A2 (en) * 2000-06-28 2002-01-03 Ward Page Faulk Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
US20040028686A1 (en) * 2001-06-28 2004-02-12 Faulk Ward Page Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplated organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
JP2004532245A (ja) * 2001-05-15 2004-10-21 ページ ダブル フォーク 癌を治療するための生体影響性化合物の標的送達
EP1395273B1 (de) 2001-05-15 2006-07-19 Faulk Pharmaceuticals, Inc. Gezielte freisetzung von arzneimitteln zur behandlung von virusinfektionen
DE60239938D1 (de) 2001-05-15 2011-06-16 Faulk Pharmaceuticals Inc Verfahren zur herstellung eines homogenen doxorubicin-transferrin kojugates
WO2002091992A2 (en) * 2001-05-16 2002-11-21 Faulk Pharmaceuticals, Inc. Targeted delivery of drugs for the treatment of parasitic infections
CA2449517A1 (en) * 2001-06-08 2002-12-19 Utah Ventures Ii, L.P. Tissue-specific endothelial membrane proteins
JP4106026B2 (ja) 2001-11-28 2008-06-25 アプレラ コーポレイション 選択的な核酸の単離方法および組成物
WO2003086272A2 (en) * 2002-04-16 2003-10-23 Kamada Ltd. Ultrapure transferrin for pharmaceutical compositions
EP1620564A4 (de) * 2003-04-18 2008-03-12 Cytovia Inc Verfahren zur behandlung von auf apoptoseinduktion reagierenden krankheiten und screening-tests
US20040220085A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Compositions for nucleic acid delivery
US20040220390A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for the treatment of tumors
US20040219104A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods for treatment of tumors
US20040219102A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Compositions for drug delivery
US20040219101A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for treatment of tumors
US20040220084A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods for nucleic acid delivery
US20040219097A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for the diagnosis, imaging and treatment of tumors
US20040219103A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods useful for the diagnosis, imaging and treatment of tumors
US20040219100A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for the treatment of tumors
US20040220121A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods for drug delivery
US20100015051A1 (en) * 2004-09-30 2010-01-21 Labhasetwar Vinod D Transferrin-conjugated nanoparticles for increasing efficacy of a therapeutic agent
CN1686562A (zh) * 2005-03-31 2005-10-26 南京大学 一种转铁蛋白与生物还原剂的结合物及其制备方法
EP2216341A1 (de) 2009-02-10 2010-08-11 Novozymes Biopharma UK Limited Transferrinvarianten und -konjugate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2108528A1 (de) * 1971-02-23 1972-09-21 Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt Verfahren zur Herstellung von mit Indium 113m markiertem Humantransfernn
DE2150000A1 (de) * 1971-10-07 1973-04-12 Hoechst Ag Metall-transferrin-aggregate, ihre herstellung und ihre verwendung als diagnosticum
DE2239791A1 (de) * 1972-08-12 1974-02-21 Hoechst Ag Verfahren zur herstellung von mit indium-113m markiertem humantransferrin
DE2964024D1 (en) * 1978-10-02 1982-12-16 Procter & Gamble Liposomes for drug delivery and composition containing a liposome drug system
DE3070278D1 (en) * 1979-10-11 1985-04-18 Fujisawa Pharmaceutical Co Peptides, processes for their preparation and pharmaceutical compositions containing them
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4447547A (en) * 1980-04-09 1984-05-08 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
US4448762A (en) * 1980-11-03 1984-05-15 The United States Of America As Represented By The United States Department Of Energy Complex of transferrin with ruthenium for medical applications
US4448763A (en) * 1980-11-10 1984-05-15 The University Of Kentucky Research Foundation Alteration of gallium biodistribution using indium complexes for enhanced early imaging
US4434156A (en) * 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
JPS60126231A (ja) * 1983-12-09 1985-07-05 Seitai Kagaku Kenkyusho:Kk 放射性診断剤

Also Published As

Publication number Publication date
DE3682780D1 (de) 1992-01-16
WO1987000756A1 (en) 1987-02-12
EP0272257A1 (de) 1988-06-29
US5000935A (en) 1991-03-19
EP0272257B1 (de) 1991-12-04
GB8519457D0 (en) 1985-09-11
JPS63502747A (ja) 1988-10-13
US4895714A (en) 1990-01-23
AU6198086A (en) 1987-03-05

Similar Documents

Publication Publication Date Title
ATE69956T1 (de) Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren.
ES529020A0 (es) Procedimiento para la obtencion de preparados para realizar diagnosticos medicos.
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
DE68918121D1 (de) Vorrichtung für Röntgenstrahlentomographie.
DE3680924D1 (de) Metall-radionuklid markiertes protein fuer diagnose und therapie.
FR2597326B1 (fr) Procede pour identifier des lesions tissulaires eventuelles lors de l'application medicale d'un son de haute energie.
DE3272377D1 (en) An x-ray computerized tomographic apparatus
JPS57209037A (en) X-ray diagnostic apparatus
GB2203831B (en) Apparatus and method for the diagnosis of malignant tumours
DE3782440D1 (de) Verfahren und ausruestung zur herstellung von radioaktivmarkierten antikoerpern fuer die in-vivo-krebsdiagnose und therapie.
DE69017370D1 (de) Röntgenuntersuchungsapparat.
IT8020661A0 (it) Metodo e apparecchiatura per la formazione di immagini mediante ultrasuoni.
ZA862057B (en) Boronic acid adducts of technetium-99m dioxime complexes
NO163435C (no) Pasientstol for roentgenundersoekelser.
NO830570L (no) Antistoffer og antigener for diagnose og behandling av cancer
PT69525A (fr) Installation de traite d'animaux en particulier des brebis
DE69330494D1 (de) Radioaktiv markierte somatostatin
DE3163087D1 (en) Radioactive diagnostic agent for bone scanning and non-radioactive carrier therefor
JPS57195446A (en) X-ray diagnostic apparatus
DE69232554D1 (de) Einen Liganden enthaltendes Arzneimittel zur Behandlung und/oder Diagnose von Weichgeweben-Tumoren
DE69010033D1 (de) Röntgenuntersuchungsapparat.
GB2006566A (en) Tomographic imaging system
DE2861257D1 (en) Diagnostic kit for blood pool imaging
ATE25336T1 (de) Mittel fuer die scintigraphie.
DE3669254D1 (de) Roentgendiagnostikanlage mit roentgenbildverstaerker.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties